Oxywise Medox Profile
Key Indicators
- Authorised Capital ₹ 6.50 M
as on 21-12-2024
- Paid Up Capital ₹ 6.44 M
as on 21-12-2024
- Company Age 22 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 8.00 M
as on 21-12-2024
About Oxywise Medox
The Corporate was formerly known as Paramount Overseas Private Limited. The Company is engaged in the Home & Lifestyle Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.50 M and a paid-up capital of Rs 6.44 M.
The company has closed loans amounting to ₹8.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Anilkumar Agarwal, Surbhi Agrawal, Aniruddh Agrawal, and Two other members serve as directors at the Company.
- CIN/LLPIN
U29100DL2002PTC117537
- Company No.
117537
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Oct 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Oxywise Medox?
Board Members(5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Aniruddh Agrawal | Director | 14-Mar-2018 | Current |
Surbhi Agrawal | Director | 03-Jan-2009 | Current |
Anilkumar Agarwal | Director | 03-Jan-2009 | Current |
Dindayakar Prasad | Director | 14-Mar-2018 | Current |
Vijay Gupta | Director | 14-Mar-2018 | Current |
Financial Performance of Oxywise Medox.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Oxywise Medox?
Unlock access to Oxywise Medox's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Airox Nigen Equipments Private LimitedActive 30 years 2 months
Anilkumar Agarwal and Surbhi Agrawal are mutual person
- Anaerobic Biogas Innovation & Technologi Es LlpActive 5 years 4 months
Anilkumar Agarwal and Surbhi Agrawal are mutual person
- Airshuddhi Engineers & Consultancy LlpActive 4 years 11 months
Anilkumar Agarwal and Aniruddh Agrawal are mutual person
- Airox Green Energy Private LimitedActive 1 year 10 months
Anilkumar Agarwal and Surbhi Agrawal are mutual person
- Airox Nigen Projects Private LimitedActive 15 years 11 months
Anilkumar Agarwal and Surbhi Agrawal are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Haryana Financial Corporation Creation Date: 24 Feb 2006 | ₹8.00 M | Satisfied |
How Many Employees Work at Oxywise Medox?
Unlock and access historical data on people associated with Oxywise Medox, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oxywise Medox, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oxywise Medox's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.